Find us on Social Media:

Alzheimer's Disease
View All 16 Treatments
Click Wheel to discover your Treatment options


Alzheimer's Disease and Glutamate Blockers

Written by ritasharma.

Memantine is the first drug approved by the US Food and Drug Administration (FDA) for treatment of moderate to severe Alzheimer’s disease. (Cholinesterase inhibitors are approved for mild to moderate disease). Improvements in daily functioning and cognition (thinking) have been observed in Alzheimer’s patients.

Effect of Glutamate Blockers on Alzheimer's Disease

Memantine (Namenda) is a newer type of medicine that acts by blocking the effects of the chemical glutamate at a specific receptor in the brain (the NMDA receptor). It is thought to decrease neurotoxicity. Memantine should not be used if you have severe kidney impairment.

Read more details about Glutamate Blockers.

Possible side effects of memantine include:

  • Headache
  • Confusion
  • Nausea, vomiting
  • Constipation
  • Drowsiness
  • Hallucinations
  • Cough
  • Diarrhea

Click Here to See All 16 Treatments for Alzheimer's Disease

FoundHealth has 16 treatments for Alzheimer's Disease!
See all Alzheimer's Disease Treatment options and start building your care plan today.



No one has made any comments yet. Be the first!

Your Comment